Friday, October 30, 2026 · Edition updated 6:00 AM ETFRI, OCT 30 · 6 AM ET editionNext edition in Next --:--:--

Pharmacological downregulation of Fetuin-A attenuates TLR4-mediated neuroinflammation in aged rats with minimal hepatic encephalopathy

Research in animals or cells · Biogerontology · Oct 24, 2026

What this means

Minimal hepatic encephalopathy (MHE) is a neurological complication associated with chronic liver disease characterized by subtle cognitive impairment and neuroinflammation, particularly in the aging population. However, the molecular mechanisms underlying age-associated MHE remain poorly understood.

A plain-English summary is on its way. Until then, this is the start of the authors' own summary.

Tested inAnimals
Who it was tested in
Animals or cells
Kind of research
Research in animals or cells

The science

Original title
Pharmacological downregulation of Fetuin-A attenuates TLR4-mediated neuroinflammation in aged rats with minimal hepatic encephalopathy.
Authors
Singh VV, Thakur P, Prasad SK et al.
Journal
Biogerontology
Published
Oct 24, 2026
Study type
Lab or animal study · indexed as animal research

Abstract

Minimal hepatic encephalopathy (MHE) is a neurological complication associated with chronic liver disease characterized by subtle cognitive impairment and neuroinflammation, particularly in the aging population. However, the molecular mechanisms underlying age-associated MHE remain poorly understood. The present study investigated the role of Fetuin-A-mediated neuroinflammation and its potential as a therapeutic target in the management of MHE in old rats using pioglitazone in a thioacetamide (TAA)-induced MHE model in aged rats. Old male rats were administered TAA (50 mg/kg) for 14 days to induce MHE, followed by pioglitazone treatment (3 mg/kg) for 7 days. Western blot and immunofluorescence analyses revealed elevated hippocampal Fetuin-A expression in MHE rats, accompanied by activation of the TLR4/MyD88/NF-κB signaling pathway and increased inflammatory cytokines (IL-6 and TNF-α). Pioglitazone treatment significantly reduced Fetuin-A expression and was accompanied by reduced TLR4, MyD88 and nuclear NF-κB expression, and by decreased astrocyte activation Furthermore, histological and Golgi-Cox analyses demonstrated restoration of neuronal density, dendritic arborization, and spine density in the hippocampus of pioglitazone-treated old MHE rats. Behavioral analyses further confirmed the molecular and histological findings. Thus, elevated hippocampal Fetuin-A is associated with TLR4/MyD88/NF-κB activation in aged MHE rats, and its pharmacological reduction by pioglitazone is accompanied by reduced neuroinflammation, restored hippocampal cytoarchitecture and recovered recognition memory. A causal role for Fetuin-A remains to be established by direct perturbation.

Read it on PubMed ↗

Singh VV, Thakur P, Prasad SK et al. Pharmacological downregulation of Fetuin-A attenuates TLR4-mediated neuroinflammation in aged rats with minimal hepatic encephalopathy. Biogerontology. 2026. doi:10.1007/s10522-026-10533-x. PMID: 42925439. https://pubmed.ncbi.nlm.nih.gov/42925439/

Report a problem